SAGE THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.04 USD | -0.95% |
|
+8.73% | -35.03% |
| 25/04 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
| 25/04 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 16.42 | 19.04 | 26.55 |
| Spread/Res. | -14.25% | -26.05% | -46.97% |
| Spread/Supp. | +12.01% | +12.01% | +5.63% |
| Support | 12.57 | 12.57 | 13.33 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- SAGE Stock
- Charts Sage Therapeutics, Inc.
